Opko Health to sell more assets to LabCorp
Labcorp to Buy Some OPKO BioReference Assets for Up to $225 Million
Labcorp Holdings has signed a deal to buy certain assets of OPKO Health's BioReference Health unit for up to $225 million. Labcorp on Tuesday said it will pay $192.5 million at closing for BioReference's laboratory testing businesses, which is focused on oncology and oncology-related clinical testing services across the U.S.
Shares of OPKO Health (NASDAQ:OPK) climbed 4% in after-hours trading Thursday following a better-than-expected Q4 earnings report. OPKO (NASDAQ:OPK) reported a net profit of $0.01 per share on revenue ...
Operator Good day, and welcome to the OPKO Health fourth quarter 2024 financial results conference call. All participants will be in a listen-only mode. [Operator instructions] After today's ...
Labcorp (LH) and OPKO Health (OPK) announced that they have entered into an agreement for Labcorp to acquire select assets of BioReference ...
HC Wainwright dropped their Q2 2025 earnings per share (EPS) estimates for OPKO Health in a note issued to investors on Monday, March 3rd. HC Wainwright analyst Y. Chen now forecasts that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback